Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy

被引：0

作者：

Altini, M. ^{[1
]}

Massa, I. ^{[1
]}

Balzi, W. ^{[1
]}

Gentili, N. ^{[1
]}

Foca, F. ^{[1
]}

Danesi, V. ^{[1
]}

Manunta, S. ^{[1
]}

Ejzykowicz, F. ^{[2
]}

Chandwani, S. ^{[3
]}

Burgio, M. ^{[1
]}

Cravero, P. ^{[1
]}

Verlicchi, A. ^{[1
]}

Bronte, G. ^{[1
]}

Crino, L. ^{[1
]}

Delmonte, A. ^{[1
]}

机构：

[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumor Irst, Meldola, Italy

[2] Merck & Co Inc, Oncol Prod Line, Core, Kenilworth, NJ USA

[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

treatment pattern; real-world study; Outcomes;

D O I：

10.1016/j.jtho.2019.08.2369

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP1.16-04

引用

页码：S1065 / S1066

页数：2

共 50 条

[1] Real-world treatment patterns for metastatic non-small cell lung cancer at IRST Italy
Altini, M.
Massa, I.
Balzi, W.
Gentili, N.
Foca, F.
Danesi, V.
Manunta, S.
Burgio, M. A.
Cravero, P.
Ejzykowicz, F.
Chandwani, S.
Delmonte, A.
ANNALS OF ONCOLOGY, 2019, 30
[2] Real-world (RW) clinical outcomes of patients with metastatic non-small cell lung cancer (mNSCLC) in the United Kingdom
Lester, J.
Escriu, C.
Khan, S.
Hudson, E.
Mansy, T.
Conn, A.
Chan, S.
Powell, C.
Brock, J.
Conibear, J.
Nelless, L.
Nayar, V.
Zhuo, X.
Durand, A.
Amin, A.
Martin, P.
Zhang, X.
Pawar, V.
ANNALS OF ONCOLOGY, 2020, 31 : S878 - S879
[3] Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy
Paoletti, Martina
Bini, Chiara
Marcellusi, Andrea
Mennini, Francesco Saverio
CLINICAL DRUG INVESTIGATION, 2024, 44 (08) : 601 - 609
[4] Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancer (mNSCLC)
Popat, S.
Brustugun, T.
Cadranel, J.
Felip, E.
Garassino, M. C.
Griesinger, F.
Helland, A.
Hochmair, M. J.
Perol, M.
Bent-Ennakhil, N.
Kruhl, C.
Novello, S.
ANNALS OF ONCOLOGY, 2020, 31 : S866 - S866
[5] LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World
Golozar, A.
Collins, J.
Fraeman, K.
Nordstrom, B.
Mcewen, R.
Shire, N.
Higgs, B.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S223 - S224
[6] Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer (MNSCLC) with Brain Metastases Treated with Pembrolizumab
Sun, L.
Davis, C.
Marmarelis, M.
Singh, A.
Berman, A.
Feigenberg, S.
Levin, W.
Bauml, J.
Cohen, R.
Langer, C.
Aggarwal, C.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1131 - S1131
[7] The evolving diagnostic and treatment landscape in metastatic non-small cell lung cancer (mNSCLC) across Europe: A real world evidence survey
Bailey, H.
Lee, A.
Eccles, L.
Yuan, Y.
Khela, K.
Hall, J.
Last, M.
Varol, N.
ANNALS OF ONCOLOGY, 2021, 32 : S1421 - S1421
[8] COGNITIVE CONCERNS AND PERFORMANCE IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC)
Eggen, Annemarie
Richard, Nadine
Shen, Gerald
Shultz, David
Leighl, Natasha
Liu, Geoffrey
Sun, Alexander
Bosma, Ingeborg
Reyners, Anna
Jalving, Mathilde
Rodin, Gary
Edelstein, Kim
NEURO-ONCOLOGY, 2019, 21 : 159 - 159
[9] Treatment patterns and real-world clinical outcomes of metastatic non-small cell lung cancer patients in the immunotherapy era
Moser, S. Sharman
Apter, L.
Arunachalam, A.
Gazit, S.
Chodick, G.
Siegelmann-Danieli, N.
ANNALS OF ONCOLOGY, 2023, 34
[10] Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study
Bodd, Monica H.
Locke, Susan C.
Wolf, Steve P.
Antonia, Scott
Crawford, Jeffrey
Hartman, John
Herring, Kris W.
Ready, Neal E.
Stinchcombe, Thomas E.
Troy, Jesse D.
Williams, Chakita
Clarke, Jeffrey M.
LeBlanc, Thomas W.
LUNG CANCER, 2023, 175 : 17 - 26

← 1 2 3 4 5 →